Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rebamipide Versus Diquafosol-Cyclosporine for Perioperative Dry Eye Disease in Cataract Surgery: A Randomized Trial

NCT07397936 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07397936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07397936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rebamipide Versus Diquafosol-Cyclosporine for Perioperative Dry Eye Disease in Cataract Surgery: A Randomized Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2024
Completion date
May 1, 2025
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, dry eye disease (ded)